Trials / Terminated
TerminatedNCT01442363
A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Braintree Laboratories · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This randomized, placebo-controlled, parallel, multi-center, double-blind pilot study is designed to determine the effects of BLI-1300 ointment on perianal pain associated with active Perianal Crohn's Disease (PCD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BLI-1300 low dose | topical ointment |
| DRUG | BLI-1300 high dose | topical ointment |
| DRUG | placebo | topical ointment |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2011-09-28
- Last updated
- 2023-11-13
- Results posted
- 2023-11-13
Locations
17 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01442363. Inclusion in this directory is not an endorsement.